Copyright
©The Author(s) 2021.
World J Hepatol. Mar 27, 2021; 13(3): 375-383
Published online Mar 27, 2021. doi: 10.4254/wjh.v13.i3.375
Published online Mar 27, 2021. doi: 10.4254/wjh.v13.i3.375
Ref. | Year | Country | Study design | Follow-up period | Sample size | Donor type | Mean age | Concurrent therapy |
Alloway et al[11] | 2014 | United States | Phase-II, 3-sequence, open-label, multicenter, prospective study | 1 yr | 59 | NR | 49.8 | Mycophenolate mofetil |
Kim et al[13] | 2016 | South Korea | 2-armed, parallel group, prospective, randomized, open-label, phase IV | 1 yr | 79 | Deceased | 54 | NR |
Sańko-Resmer et al[14] | 2012 | United Kingdom | Multicentre, open-label, single-sequence, crossover, phase IIIb | 3 mo | 98 | NR | 55 | None |
Shin et al[17] | 2018 | South Korea | Phase IV, randomized, open-label, comparative, single-center study | 6 mo | 100 | NR | 52 | Corticosteroid, mycophenolate mofetil, and basiliximab. |
Trunečka et al[15] | 2010 | 16 countries | 1:1-randomized, double-blind, double-dummy, two-arm, parallel-group phase III, comparative study | 1 yr | 471 | NR | 52 | Mycophenolate sodium |
DuBay et al[12] | 2019 | United States | Phase II, open label, multicenter, randomized trial | 1 yr | 29 | Deceased | 54.4 | Mycophenolate mofetil, mycophenolic acid sodium, prednisone, or azathioprine |
Fischer et al[16] | 2010 | Germany | Randomized, phase II, multicenter, open-label, prospective trial | 6 wk | 129 | NR | 47 | Anti-fungal, antibiotics, anti-hypertensives, antiepileptics and rifampicin) |
- Citation: Bzeizi KI, Albenmousa A, Shawkat M, Ahmed Z, Alabbad S, Al-Hamoudi W, Troisi R, Broering D. Efficacy and safety of once daily tacrolimus compared to twice daily tacrolimus after liver transplantation. World J Hepatol 2021; 13(3): 375-383
- URL: https://www.wjgnet.com/1948-5182/full/v13/i3/375.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i3.375